دورية أكاديمية
Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid.
العنوان: | Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid. |
---|---|
المؤلفون: | Velazquez FN; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA., Hernandez-Corbacho M; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA., Trayssac M; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA., Stith JL; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA., Bonica J; Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA; Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11790, USA., Jean B; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA., Pulkoski-Gross MJ; Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA; Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11790, USA., Carroll BL; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11790, USA., Salama MF; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA; Department of Biochemistry, Faculty of Veterinary Medicine, Mansoura University, Mansoura, Egypt., Hannun YA; Department of Medicine, Stony Brook University, Stony Brook, NY 11794, USA; Cancer Center, Stony Brook University, Stony Brook, NY 11794, USA., Snider AJ; Department of Nutritional Sciences, College of Agriculture and Life Sciences, University of Arizona, Tucson, AZ 85721, USA. Electronic address: ashleysnider@arizona.edu. |
المصدر: | Cellular signalling [Cell Signal] 2021 Mar; Vol. 79, pp. 109875. Date of Electronic Publication: 2020 Dec 05. |
نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Review |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 8904683 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3913 (Electronic) Linking ISSN: 08986568 NLM ISO Abbreviation: Cell Signal Subsets: MEDLINE |
أسماء مطبوعة: | Publication: Oxford : Elsevier Science Ltd Original Publication: Oxford ; New York : Pergamon Press, 1988- |
مواضيع طبية MeSH: | Signal Transduction*, Aging/*metabolism , Lysophospholipids/*metabolism , Neoplasm Proteins/*metabolism , Neoplasms/*metabolism , Sphingolipids/*metabolism , Sphingosine/*analogs & derivatives, Aging/genetics ; Aging/pathology ; Animals ; Humans ; Inflammation/genetics ; Inflammation/metabolism ; Inflammation/pathology ; Laboratories ; Lysophospholipids/genetics ; Neoplasm Proteins/genetics ; Neoplasms/genetics ; Neoplasms/pathology ; Sphingolipids/genetics ; Sphingosine/genetics ; Sphingosine/metabolism |
مستخلص: | Sphingolipids and their synthetic enzymes have emerged as critical mediators in numerous diseases including inflammation, aging, and cancer. One enzyme in particular, sphingosine kinase (SK) and its product sphingosine-1-phosphate (S1P), has been extensively implicated in these processes. SK catalyzes the phosphorylation of sphingosine to S1P and exists as two isoforms, SK1 and SK2. In this review, we will discuss the contributions from the laboratory of Dr. Lina M. Obeid that have defined the roles for several bioactive sphingolipids in signaling and disease with an emphasis on her work defining SK1 in cellular fates and pathobiologies including proliferation, senescence, apoptosis, and inflammation. (Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.) |
References: | J Biol Chem. 2002 Sep 20;277(38):35257-62. (PMID: 12124383) Prostaglandins Other Lipid Mediat. 2012 Dec;99(3-4):124-30. (PMID: 22940715) Prog Lipid Res. 2006 May;45(3):250-78. (PMID: 16574237) Breast Cancer Res Treat. 2008 Nov;112(1):41-52. (PMID: 18058224) J Biol Chem. 1994 Oct 21;269(42):26040-4. (PMID: 7929315) Science. 2001 Mar 2;291(5509):1800-3. (PMID: 11230698) Nature. 1993 Oct 7;365(6446):557-60. (PMID: 8413613) Curr Biol. 2000 Nov 30;10(23):1527-30. (PMID: 11114522) J Cell Biol. 1999 Apr 5;145(1):99-108. (PMID: 10189371) J Allergy Clin Immunol. 2013 Feb;131(2):501-11.e1. (PMID: 22939756) J Biol Chem. 2004 May 7;279(19):20546-54. (PMID: 14988393) Int J Colorectal Dis. 2012 Dec;27(12):1569-78. (PMID: 22684547) FASEB J. 2009 Jan;23(1):143-52. (PMID: 18815359) Anticancer Agents Med Chem. 2012 May;12(4):340-63. (PMID: 21707511) Cell. 2012 Mar 2;148(5):988-1000. (PMID: 22385963) Oncotarget. 2014 Aug 15;5(15):5920-33. (PMID: 25153718) Prostaglandins Other Lipid Mediat. 2006 Mar;79(1-2):126-40. (PMID: 16516816) FEBS Lett. 2006 Nov 13;580(26):6047-54. (PMID: 17064696) Crit Rev Biochem Mol Biol. 2011 Oct;46(5):365-75. (PMID: 21864225) Biochem J. 2012 Feb 1;441(3):789-802. (PMID: 22248339) Mech Ageing Dev. 2013 Nov-Dec;134(11-12):548-59. (PMID: 24269881) PLoS One. 2014 Dec 02;9(12):e113998. (PMID: 25460165) Biochem Biophys Res Commun. 2015 Aug 7;463(4):954-60. (PMID: 26071354) J Biol Chem. 2012 Sep 14;287(38):31794-803. (PMID: 22833671) Biochem J. 2000 Sep 1;350 Pt 2:429-41. (PMID: 10947957) Am J Respir Crit Care Med. 2014 Nov 1;190(9):1032-43. (PMID: 25180446) Trends Cell Biol. 2018 Jun;28(6):436-453. (PMID: 29477613) Am J Pathol. 2010 Nov;177(5):2205-15. (PMID: 20889557) J Biol Chem. 1997 Apr 11;272(15):9609-12. (PMID: 9092485) J Immunol. 2010 Aug 15;185(4):2570-9. (PMID: 20644167) J Lipid Res. 2019 May;60(5):913-918. (PMID: 30846529) Cell Signal. 2005 Oct;17(10):1203-17. (PMID: 16038795) Front Genet. 2017 Sep 21;8:132. (PMID: 28983319) J Clin Invest. 2009 Jul;119(7):1871-9. (PMID: 19603543) Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):e1-6. (PMID: 12524240) Am J Pathol. 2010 Jul;177(1):436-46. (PMID: 20522645) DNA Cell Biol. 2019 Nov;38(11):1338-1345. (PMID: 31464523) Oncotarget. 2018 Feb 26;9(21):15635-15649. (PMID: 29643998) J Biol Chem. 2013 Sep 20;288(38):27667-27679. (PMID: 23935096) Leukemia. 2019 Dec;33(12):2884-2897. (PMID: 31097785) Oncogene. 2012 Mar 1;31(9):1166-75. (PMID: 21765468) Leukemia. 2008 May;22(5):971-9. (PMID: 18401414) FASEB J. 2006 Jan;20(1):184-6. (PMID: 16278291) Prostaglandins Other Lipid Mediat. 2017 May;130:47-56. (PMID: 28377281) J Biol Chem. 1997 Jun 27;272(26):16474-81. (PMID: 9195956) Cancer Prev Res (Phila). 2011 Mar;4(3):454-62. (PMID: 21209394) Sci Rep. 2018 Jan 29;8(1):1756. (PMID: 29379030) Cancer Cell. 2013 Jan 14;23(1):107-20. (PMID: 23273921) Inflamm Allergy Drug Targets. 2011 Dec;10(6):464-71. (PMID: 21864273) J Biol Chem. 2007 Jun 8;282(23):16718-28. (PMID: 17283068) J Biol Chem. 2004 Dec 24;279(52):53994-4001. (PMID: 15485866) Biochem J. 1998 Sep 1;334 ( Pt 2):479-85. (PMID: 9716508) FASEB J. 2015 Jul;29(7):2803-13. (PMID: 25805832) Nat Rev Drug Discov. 2010 Nov;9(11):883-97. (PMID: 21031003) Adv Biol Regul. 2016 Jan;60:160-165. (PMID: 26601898) FASEB J. 2016 Dec;30(12):4159-4171. (PMID: 27609772) Cancer Res. 2019 Aug 15;79(16):4211-4226. (PMID: 31239273) J Biol Chem. 2010 Apr 16;285(16):11818-26. (PMID: 20172858) Carcinogenesis. 2017 Dec 7;38(12):1218-1227. (PMID: 29028945) Biochim Biophys Acta. 2005 Dec 30;1738(1-3):72-81. (PMID: 16414307) Nat Rev Mol Cell Biol. 2008 Feb;9(2):139-50. (PMID: 18216770) Arthritis Rheum. 2006 Mar;54(3):742-53. (PMID: 16508938) PLoS One. 2019 Jun 7;14(6):e0218090. (PMID: 31173610) Nature. 2014 May 22;509(7501):439-46. (PMID: 24848057) J Biomed Mater Res A. 2019 Jan;107(1):25-37. (PMID: 30422374) Trends Cell Biol. 2001 Nov;11(11):S27-31. (PMID: 11684439) Nat Immunol. 2010 Nov;11(11):1047-56. (PMID: 20852647) Oncotarget. 2016 Apr 19;7(16):21124-44. (PMID: 27008706) J Immunol. 2008 Dec 1;181(11):8010-7. (PMID: 19017993) J Biol Chem. 2011 Jul 15;286(28):25352-62. (PMID: 21613224) Infect Immun. 2015 Jul;83(7):2705-13. (PMID: 25895971) Biochem J. 1996 May 15;316 ( Pt 1):25-8. (PMID: 8645213) J Biol Chem. 2011 Aug 12;286(32):27855-62. (PMID: 21693702) Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Nov;1863(11):1413-1422. (PMID: 30591148) Proc Natl Acad Sci U S A. 1996 May 28;93(11):5325-8. (PMID: 8643573) J Immunol. 2004 Aug 1;173(3):1596-603. (PMID: 15265887) Oncogenesis. 2016 Mar 14;5:e209. (PMID: 26974204) PLoS One. 2014 Feb 27;9(2):e90362. (PMID: 24587339) FASEB J. 2009 Feb;23(2):405-14. (PMID: 18824518) J Biol Chem. 1996 Oct 4;271(40):24800-5. (PMID: 8798752) Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14196-201. (PMID: 9826677) Cell Physiol Biochem. 2010;26(1):97-104. (PMID: 20502009) Carcinogenesis. 2008 Mar;29(3):491-9. (PMID: 18204081) J Biol Chem. 1996 May 31;271(22):13169-74. (PMID: 8662781) FASEB J. 2010 Aug;24(8):2727-38. (PMID: 20335228) PLoS Genet. 2011 May;7(5):e1002063. (PMID: 21625621) Cancer Res. 2012 Feb 1;72(3):726-35. (PMID: 22298596) J Biol Chem. 2012 Mar 23;287(13):10145-10155. (PMID: 22311981) Mol Cancer Res. 2009 Jun;7(6):890-6. (PMID: 19531570) Mol Cell Biochem. 2007 Nov;305(1-2):27-34. (PMID: 17577630) Gastroenterology. 2011 May;140(6):1807-16. (PMID: 21530747) Clin Cancer Res. 2011 Apr 1;17(7):1839-49. (PMID: 21325072) J Cell Biochem. 1996 Mar 15;60(4):529-37. (PMID: 8707892) FASEB J. 2001 Dec;15(14):2669-79. (PMID: 11726543) Mol Cell Biol. 2002 Nov;22(22):7758-68. (PMID: 12391145) Crit Rev Biochem Mol Biol. 2011 Aug;46(4):342-51. (PMID: 21787121) J Thromb Haemost. 2007 Apr;5(4):835-45. (PMID: 17388800) J Biol Chem. 2001 Aug 31;276(35):32506-14. (PMID: 11441001) Exp Hematol. 2011 Jun;39(6):653-665.e6. (PMID: 21392556) Am J Transl Res. 2015 Nov 15;7(11):2346-54. (PMID: 26807182) BMB Rep. 2019 Mar;52(3):220-225. (PMID: 30885289) J Biol Chem. 2002 Mar 8;277(10):7996-8003. (PMID: 11777919) J Biol Chem. 2009 Feb 20;284(8):4786-95. (PMID: 19095642) Can J Cardiol. 2015 Mar;31(3):357-63. (PMID: 25746025) Nat Rev Cancer. 2004 Aug;4(8):604-16. (PMID: 15286740) FEBS Open Bio. 2017 Dec 08;8(1):27-40. (PMID: 29321954) J Biol Chem. 2011 May 6;286(18):15929-42. (PMID: 21388949) J Biol Chem. 2010 Oct 15;285(42):32476-85. (PMID: 20679347) Br J Pharmacol. 2017 Jan;174(2):210-222. (PMID: 27864936) Acta Neuropathol Commun. 2014 Jan 27;2:12. (PMID: 24468113) Exp Cell Res. 2000 Dec 15;261(2):303-11. (PMID: 11112337) J Gerontol A Biol Sci Med Sci. 2001 Jan;56(1):B8-19. (PMID: 11193225) Cell Signal. 2017 Apr;32:85-92. (PMID: 28108260) Biochem J. 2013 Feb 1;449(3):661-72. (PMID: 23106337) J Biol Chem. 2008 Feb 8;283(6):3365-3375. (PMID: 18055454) Bone. 2020 Jan;130:115087. (PMID: 31648078) J Lipid Res. 2011 Jan;52(1):68-77. (PMID: 20940143) FASEB J. 2015 Nov;29(11):4654-69. (PMID: 26209696) J Leukoc Biol. 2018 Oct;104(4):843-853. (PMID: 29882996) Structure. 2013 May 7;21(5):798-809. (PMID: 23602659) Nat Cell Biol. 2014 Jul;16(7):652-62. (PMID: 24929359) PLoS One. 2013 Jul 19;8(7):e70087. (PMID: 23894595) Front Pharmacol. 2016 Apr 15;7:94. (PMID: 27148053) Cancer Cell. 2002 Feb;1(1):19-30. (PMID: 12086884) Nat Commun. 2018 Apr 16;9(1):1479. (PMID: 29662056) Mol Cancer Ther. 2009 Apr;8(4):809-20. (PMID: 19372554) Subcell Biochem. 2008;49:413-40. (PMID: 18751921) Oncogene. 2016 Oct 20;35(42):5501-5514. (PMID: 27065335) Exp Cell Res. 2002 Nov 15;281(1):115-27. (PMID: 12441135) Nat Rev Cancer. 2010 Jul;10(7):489-503. (PMID: 20555359) J Biol Chem. 2001 Jul 6;276(27):24901-10. (PMID: 11335714) J Immunol. 2008 Mar 15;180(6):4323-9. (PMID: 18322246) Prostaglandins Other Lipid Mediat. 2020 Aug;149:106423. (PMID: 32006664) Rheumatol Int. 2013 Oct;33(10):2677-81. (PMID: 23011090) FASEB J. 2018 May;32(5):2339-2353. (PMID: 29259036) Age (Dordr). 2012 Aug;34(4):935-47. (PMID: 21894448) Mol Cancer Res. 2009 Jan;7(1):23-32. (PMID: 19147534) FASEB J. 2018 Mar;32(3):1716-1728. (PMID: 29133339) Biochim Biophys Acta. 1999 Jul 30;1439(2):291-8. (PMID: 10425402) Annu Rev Physiol. 2013;75:685-705. (PMID: 23140366) Science. 1993 Mar 19;259(5102):1769-71. (PMID: 8456305) Biochem J. 2012 May 15;444(1):79-88. (PMID: 22397330) Pulm Circ. 2019 Jan-Mar;9(1):2045894018816977. (PMID: 30430898) Life Sci. 2010 Sep 11;87(11-12):350-7. (PMID: 20624405) Cell Death Differ. 1999 Jul;6(7):596-8. (PMID: 10515704) Nature. 2010 Jun 24;465(7301):1084-8. (PMID: 20577214) J Biol Chem. 2005 Dec 30;280(52):43030-8. (PMID: 16243846) Adv Enzyme Regul. 2002;42:113-29. (PMID: 12123710) J Lipid Res. 2018 Mar;59(3):462-474. (PMID: 29326159) Biochem Biophys Res Commun. 2015 Dec 4-11;468(1-2):8-13. (PMID: 26549227) J Biol Chem. 2015 Oct 16;290(42):25356-73. (PMID: 26318452) Oncotarget. 2016 Jan 5;7(1):241-54. (PMID: 26540633) Nat Immunol. 2014 Mar;15(3):231-8. (PMID: 24464131) Nat Rev Mol Cell Biol. 2018 Mar;19(3):175-191. (PMID: 29165427) Biogerontology. 2002;3(6):365-72. (PMID: 12510175) FASEB J. 2006 Mar;20(3):482-4. (PMID: 16507765) Biochem Biophys Res Commun. 1996 Aug 14;225(2):392-9. (PMID: 8753774) Dig Dis Sci. 2008 Apr;53(4):997-1012. (PMID: 18058233) PLoS One. 2016 Dec 14;11(12):e0168302. (PMID: 27973607) Mech Ageing Dev. 2000 Feb 15;113(3):169-81. (PMID: 10714936) J Biol Chem. 2008 Sep 5;283(36):24707-17. (PMID: 18596045) Biochem J. 2009 Nov 11;424(2):273-83. (PMID: 19728861) J Biol Chem. 2013 Aug 2;288(31):22193-206. (PMID: 23766515) Biochem J. 1998 Sep 1;334 ( Pt 2):457-61. (PMID: 9716505) J Med Life. 2019 Apr-Jun;12(2):113-122. (PMID: 31406511) J Biol Chem. 2006 Nov 10;281(45):33931-8. (PMID: 16951403) FEBS J. 2013 Dec;280(24):6354-66. (PMID: 23879641) Oncotarget. 2016 Mar 29;7(13):16663-75. (PMID: 26934645) Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1860-1868. (PMID: 28775072) FASEB J. 2003 Aug;17(11):1411-21. (PMID: 12890694) Clin Cancer Res. 2008 Nov 1;14(21):6996-7003. (PMID: 18980995) Mol Cell. 2015 Nov 19;60(4):626-36. (PMID: 26590717) J Biol Chem. 2006 Oct 20;281(42):31399-407. (PMID: 16926156) Cell Metab. 2014 Oct 7;20(4):678-86. (PMID: 25295788) J Biol Chem. 2005 Apr 29;280(17):17196-202. (PMID: 15710602) J Histochem Cytochem. 2005 Sep;53(9):1159-66. (PMID: 15923363) J Biol Chem. 2004 Oct 22;279(43):44763-74. (PMID: 15310762) Clin Exp Gastroenterol. 2014 Jun 30;7:205-14. (PMID: 25061328) FASEB J. 2013 Aug;27(8):3155-66. (PMID: 23629860) Mol Cell Biol. 2010 Aug;30(15):3827-41. (PMID: 20516217) Aging (Albany NY). 2014 Jan;6(1):9-25. (PMID: 24457528) Prostaglandins Other Lipid Mediat. 2008 Mar;85(3-4):107-14. (PMID: 18166496) Neurology. 2012 Aug 14;79(7):633-41. (PMID: 22815558) J Clin Invest. 2018 Jul 2;128(7):2702-2712. (PMID: 30108193) Mol Neurobiol. 2019 Oct;56(10):7188-7207. (PMID: 30997640) Clin Cancer Res. 2015 Jan 15;21(2):417-27. (PMID: 25411162) Cell Death Dis. 2016 Mar 03;7:e2124. (PMID: 26938296) Cell Signal. 2010 Oct;22(10):1536-42. (PMID: 20570726) J Biomed Mater Res B Appl Biomater. 2020 Apr;108(3):1141-1156. (PMID: 31444959) J Biol Chem. 2005 Apr 22;280(16):16096-105. (PMID: 15722351) Endocr Relat Cancer. 2007 Jun;14(2):325-35. (PMID: 17639048) Int J Mol Sci. 2019 Sep 02;20(17):. (PMID: 31480728) Anticancer Res. 2019 Feb;39(2):663-670. (PMID: 30711943) J Biol Chem. 1995 Dec 22;270(51):30701-8. (PMID: 8530509) |
معلومات مُعتمدة: | P01 CA097132 United States CA NCI NIH HHS; R03 HD099467 United States HD NICHD NIH HHS; R03 NS111420 United States NS NINDS NIH HHS |
المشرفين على المادة: | 0 (Lysophospholipids) 0 (Neoplasm Proteins) 0 (Sphingolipids) 26993-30-6 (sphingosine 1-phosphate) NGZ37HRE42 (Sphingosine) |
تواريخ الأحداث: | Date Created: 20201208 Date Completed: 20220119 Latest Revision: 20220119 |
رمز التحديث: | 20221213 |
مُعرف محوري في PubMed: | PMC8244749 |
DOI: | 10.1016/j.cellsig.2020.109875 |
PMID: | 33290840 |
قاعدة البيانات: | MEDLINE |
كن أول من يترك تعليقا!